Banff study of pathologic changes in lung allograft biopsy specimens with donor-specific antibodies.

Journal Article (Journal Article;Multicenter Study)

BACKGROUND: The diagnosis of antibody-mediated rejection (AMR) in the lung transplant is still an area under investigation. We performed a blinded multicenter study to determine if any statistically significant histologic findings in transbronchial biopsy specimens from lung transplant patients correlate with the presence of donor-specific antibodies (DSAs). METHODS: We asked 9 pathologists with experience in lung transplantation to evaluate 161 lung transplant biopsy specimens for various histologic parameters. The findings were correlated with antibody status positive for DSAs, positive for non-DSAs, and no antibodies (NABs) present. The significance of each histologic variable was reviewed. RESULTS: We found no statistically significant association with acute cellular rejection, airway inflammation, or bronchiolitis obliterans and the presence or absence of antibodies. However, biopsy specimens with DSAs had a statistically significant difference vs NABs in the setting of acute lung injury, with or without diffuse alveolar damage (p = 0.0008), in the presence of capillary neutrophilic inflammation (p = 0.0014), and in samples with endotheliitis (p = 0.0155). In samples with complement 4d staining, there was a trend but no statistically significant difference between specimens associated with DSAs and specimens with NABs. CONCLUSIONS: Capillary inflammation, acute lung injury, and endotheliitis significantly correlated with DSAs. The infrequently observed diffuse staining for complement 4d limits the usefulness of this stain.

Full Text

Duke Authors

Cited Authors

  • Wallace, WD; Li, N; Andersen, CB; Arrossi, AV; Askar, M; Berry, GJ; DeNicola, MM; Neil, DA; Pavlisko, EN; Reed, EF; Remmelink, M; Weigt, SS; Weynand, B; Zhang, JQ; Budev, MM; Farver, CF

Published Date

  • January 2016

Published In

Volume / Issue

  • 35 / 1

Start / End Page

  • 40 - 48

PubMed ID

  • 26601715

Electronic International Standard Serial Number (EISSN)

  • 1557-3117

Digital Object Identifier (DOI)

  • 10.1016/j.healun.2015.08.021


  • eng

Conference Location

  • United States